Breast cancer and Graves' disease
Open Access
- 1 December 2023
- journal article
- research article
- Published by University of Nis Faculty of Medicine in AFMN Biomedicine
- Vol. 41 (1) , 146-153
Abstract
Numerous clinical trials have proven the connection between two glandular organs, in this case, the breast and the thyroid gland. The occurrence of breast cancer (BC) is increased in patients with autoimmune thyroid disease (Hashimoto's thyroiditis and Graves' disease). Patients with Graves' disease have a significantly smaller number of described cases of BC than those with diagnosed Hashimoto's thyroiditis. A 57-year-old female patient came to the emergency center with difficulty breathing. During the examination, ophthalmopathy, weakened breath sound and mastitis of both breasts were found. Hormonal analysis showed the following values: TSH 0.00 (0.3-5.5 mlU/L), FT4 32.90 (11.5-23 pmol/L), TSHRAt 19 (0.0-1.1 U/L), TPOAt 234 (0.0-12 IU/ml), TgAt > 2000 (0.0-30.0 IU/ml). A diagnosis of Graves' disease was established and therapy with thyrosuppressant was started immediately. A multi-detector computed tomography (MDCT) showed a left breast tumor with metastases in the supraclavicular and axillary lymph nodes, infiltration of the tumor into the skin and subcutaneous tissue, as well as metastases in the bones. A biopsy of the breast tumor was performed, and PH findings indicated poorly differentiated ductal carcinoma of the breast, the HER-2+ group of tumors. The early detection of thyroid disease would not lead to the development of a malignant process, and that is why doctors in their clinical work must recognize the first signs of thyroid disease in their patients and immediately start with therapy to reduce the potential risk of BC. There is a significant role in using screening tests to discover breast cancer in patients with untreated or inadequately treated hypo-and hyperthyroidism.Keywords
This publication has 24 references indexed in Scilit:
- Breast cancer populations may have an increased prevalence of thyroglobulin antibody and thyroid peroxidase antibody: a systematic review and meta-analysisBreast Cancer, 2020
- Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With HyperthyroidismJAMA Internal Medicine, 2019
- Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysisJournal of Endocrinological Investigation, 2017
- Different expression of sodium–iodide importer (NIS) between lactating breast and thyroid tissues may be due to structural difference of thyroid-stimulating hormone receptor (TSHR)Journal of Endocrinological Investigation, 2016
- HyperthyroidismThe Lancet, 2016
- Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer riskInternational Journal of Cancer, 2012
- Mechanisms of nongenomic actions of thyroid hormoneFrontiers in Neuroendocrinology, 2008
- Effects of thyroid hormones on human breast cancer cell proliferationThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissuesJournal of Endocrinological Investigation, 2006
- Breast cancer. Relationship to thyroid supplements for hypothyroidismJAMA, 1976